Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT
IntroductionT cell Ig and ITIM domain receptor (TIGIT) is a next-generation immune checkpoint predominantly expressed on activated T cells and NK cells, exhibiting an unfavorable prognostic association with various malignancies. Despite the emergence of multiple TIGIT-blocking agents entering clinic...
Main Authors: | Katty Zeven, Timo W.M. De Groof, Hannelore Ceuppens, Robin Maximilian Awad, Thomas Ertveldt, Wout de Mey, Fien Meeus, Geert Raes, Karine Breckpot, Nick Devoogdt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1268900/full |
Similar Items
-
Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use
by: Quentin Lecocq, et al.
Published: (2019-09-01) -
In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells
by: Robin Maximilian Awad, et al.
Published: (2023-11-01) -
Applications of nanobodies in brain diseases
by: Fang Zheng, et al.
Published: (2022-11-01) -
Development and Characterization of Nanobodies Targeting the Kupffer Cell
by: Fang Zheng, et al.
Published: (2021-02-01) -
Anti-Human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation
by: Jessica Bridoux, et al.
Published: (2020-09-01)